Description
Metformin Glibenclamide Capsules
Product name: Metformin Glibenclamide Capsules (II) (Kemaining)
Packing specifications: 12 capsules * 4 plates Product dosage form: Capsules Packing unit: box
Approval number: National Medicine Standard H20060239 Drug standard code: 86901381000033
Manufacturer: Changzhou Sunshine Pharmaceutical Co., Ltd.
Product barcode: 6970681300246
Metformin Glibenclamide combination capsules (II) combine a biguanide and a sulfonylurea to harness complementary mechanisms for glycemic control in type 2 diabetes research. Produced under NMPA approval H20060239, this combination is essential for labs exploring dual oral antidiabetic regimens zh.wikipedia.org+4zh.wikipedia.org+4reddit.com+4.
These capsules are designed to mimic clinical combination therapies, offering balanced glucose lowering via hepatic insulin-sensitizing effects (metformin) and pancreatic insulin secretion (glibenclamide).
Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Metformin + Glibenclamide Capsules (II) – “Ke Mailing” |
| Strength & Quantity | 12 capsules per box |
| Dosage Form | Hard gelatin capsules |
| Manufacturer | Changzhou Sunshine Pharmaceutical Co., Ltd. |
| Approval Number (NMPA) | H20060239 |
| Drug Code | 86901381000033 |
| Barcode | 6970681300246 |
| Storage | Store in sealed container, protect from moisture |
| Intended Use | For laboratory research / analytical use only |
Clinical Research Info
Mechanism of Action
Metformin activates AMPK, reduces hepatic gluconeogenesis, increases insulin sensitivity?.
Glibenclamide stimulates pancreatic beta-cell insulin release by blocking ATP-sensitive potassium channels?.
Recommended Usage (Clinical Analog)
Personalized dosing seen in clinical studies uses 1–4 capsules daily with meals, adjusted biweekly based on glycemic response?.
Known Adverse Effects
Gastrointestinal: diarrhea, nausea, metallic taste?
Metabolic: hypoglycemia, lactic acidosis (rare)
Rare issues: hepatotoxicity, blood dyscrasias, vitamin B12 deficiency?
Why Choose This Product?
Clinically relevant fixed-dose combination
Standardized capsules designed for lab dosing consistency
Regulatory traceability via NMPA approval
Enables dual-pathway research (hepatic + pancreatic glucose control)
Metformin Tablets (Biguanides)
Glibenclamide Capsules (Sulfonylurea class)
Metformin + Sitagliptin Capsules (Dual therapy combos)
Summary
Ke Mailing Metformin + Glibenclamide Capsules (II) are an ideal research-grade antidiabetic combo with dual mechanism action. With full regulatory traceability and lab-ready packaging, this product supports advanced studies in metabolic pharmacology.
Reminder: strictly for laboratory or analytical use only.


hallgren –
The effect is very good,